A detailed history of New Century Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, New Century Financial Group, LLC holds 5,014 shares of ABT stock, worth $585,635. This represents 0.21% of its overall portfolio holdings.

Number of Shares
5,014
Previous 4,836 3.68%
Holding current value
$585,635
Previous $502 Million 13.76%
% of portfolio
0.21%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$100.07 - $118.13 $17,812 - $21,027
178 Added 3.68%
5,014 $572 Million
Q2 2024

Aug 27, 2024

BUY
$100.73 - $112.44 $293,829 - $327,987
2,917 Added 152.01%
4,836 $502 Million
Q1 2024

Apr 19, 2024

BUY
$109.52 - $120.96 $4,599 - $5,080
42 Added 2.24%
1,919 $218 Million
Q4 2023

Feb 08, 2024

BUY
$90.19 - $110.4 $169,286 - $207,220
1,877 New
1,877 $207 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track New Century Financial Group, LLC Portfolio

Follow New Century Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Century Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Century Financial Group, LLC with notifications on news.